Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Weill Cornell Medicine Courses and Meetings
Avatar

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors and PD-1 and CTLA-4 Combination Immunotherapy

By Weill Cornell Medicine Courses and Meetings FEATURING Paul Chapman
By Weill Cornell Medicine Courses and Meetings FEATURING Paul Chapman
94 views
June 10, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

12:58
Incyte

Spleen Volume Reduction and Long-Term Survival in Myelofibrosis: Whe…

Feat. R. Mesa

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
Brain
08:11

Leptomeningeal Metastases: Definitions, Localization, Presentation, …

Weill Cornell Medicine Courses and Meetings

A. Boire

412 views
12:58

Leptomeningeal Metastases: Intrathecal/Systemic Treatments and Front…

Weill Cornell Medicine Courses and Meetings

A. Boire

687 views
14:10

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors a…

Weill Cornell Medicine Courses and Meetings

P. Chapman

94 views